Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Bravo, A; de Lucio, H; Sánchez-Murcia, PA; Jiménez-Ruiz, A; Petrone, PM; Gago, F; Cortés Cabrera, A.
Identification of NEK3 and MOK as novel targets for lithium.
Chem Biol Drug Des. 2019; 93(5):965-969
Doi: 10.1111/cbdd.13487
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Sánchez Murcia Pedro Alejandro
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Lithium ion, commonly used as the carbonate salt in the treatment of bipolar disorders, has been identified as an inhibitor of several kinases, including Glycogen Synthase Kinase-3β, for almost 20 years. However, both the exact mechanism of enzymatic inhibition and its apparent specificity for certain metalloenzymes are still a matter of debate. A data-driven hypothesis is presented that accounts for the specificity profile of kinase inhibition by lithium in terms of the presence of a unique protein environment in the magnesium-binding site. This hypothesis has been validated by the discovery of two novel potential targets for lithium, namely NEK3 and MOK, which are related to neuronal function.
© 2019 John Wiley & Sons A/S.
- Find related publications in this database (using NLM MeSH Indexing)
-
Antigens, Neoplasm - chemistry
-
Antigens, Neoplasm - metabolism
-
Binding Sites -
-
Glycogen Synthase Kinase 3 beta - chemistry
-
Glycogen Synthase Kinase 3 beta - metabolism
-
Humans -
-
Inhibitory Concentration 50 -
-
Ions - chemistry
-
Lithium - chemistry
-
Lithium - metabolism
-
Magnesium - chemistry
-
Magnesium - metabolism
-
Mitogen-Activated Protein Kinases - chemistry
-
Mitogen-Activated Protein Kinases - metabolism
-
Molecular Dynamics Simulation -
-
NIMA-Related Kinases - chemistry
-
NIMA-Related Kinases - metabolism
-
Protein Structure, Tertiary -
- Find related publications in this database (Keywords)
-
axonal growth
-
bipolar disorder
-
GSK3B
-
lithium
-
MOK
-
NEK3